Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Tyruko
Descriptions
Natalizumab-sztn injection is used to treat the relapsing forms (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) of multiple sclerosis (MS). This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease.
Natalizumab-sztn injection is also used to treat moderate to severe Crohn's disease (CD) when other medicines or treatments did not work well. This medicine will not cure CD, but may prevent it from occurring again.
This medicine is available only under a restricted distribution program called the Tyruko® REMS (Risk Evaluation and Mitigation Strategy) Program.
Portions of this document last updated: April 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.